Related Experiment Video
Updated: Apr 26, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
The natural course of clinically isolated syndrome in pediatric patients
Cha Gon Lee1, Bolyun Lee2, Jeehun Lee3
1Department of Pediatrics, Eulji General Hospital, College of Medicine, Eulji University, Seoul, Republic of Korea.
Insights
Clinically isolated syndrome (CIS) in children can progress to multiple sclerosis (MS). A second relapse or specific initial symptoms like brain stem dysfunction strongly predict MS development in pediatric patients.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
- Clinical Demyelinating Diseases
Background:
- Clinically isolated syndrome (CIS) is the first episode of central nervous system (CNS) symptoms suggesting demyelination in children.
- Diagnostic criteria for pediatric CNS demyelination were established in 2007.
- Understanding the natural course and prognostic factors of pediatric CIS is crucial.
Purpose of the Study:
- To investigate the natural course of pediatric CIS.
- To identify factors influencing the prognosis of pediatric CIS.
- To determine predictors of conversion to multiple sclerosis (MS) in children.
Main Methods:
- Retrospective review of medical records of pediatric patients (<18 years) with CNS events from 1997-2008.
- Analysis of clinical presentations, demographic data, and follow-up information.
- Assessment of conversion to MS based on established diagnostic criteria.
Main Results:
- 32 pediatric CIS patients identified (mean age 10.0±4.1 years).
- Optic neuritis was the most common initial presentation.
- 50% experienced a second demyelinating event; 34% developed childhood MS.
- Asymptomatic MRI lesions and CSF oligoclonal bands did not predict MS conversion.
Conclusions:
- A second relapse and initial multifocal or specific CNS dysfunction (brain stem, cerebellar, cerebral) strongly predict MS development in pediatric CIS (p=0.002).
- Predicting progression of pediatric CIS to chronic demyelinating disease remains challenging despite improved understanding.
Background:
The first episode of central nervous system (CNS) symptoms with a presumed inflammatory demyelinating cause is defined as clinically isolated syndrome (CIS) according to the 2007 consensus of the International Pediatric Multiple Sclerosis Study Group, which developed diagnostic criteria for CNS demyelination disease in children. Using this definition of CIS, we attempted to identify the natural course of pediatric patients with CIS in a single Korean institution and to determine the factors affecting their prognosis.
Methods:
We retrospectively reviewed the medical records of all pediatric patients (age <18 years old) who presented with clinical symptoms of CNS events between 1997 and 2008.
Results:
We identified 32 patients with CIS. Their mean age with standard deviation was 10.0±4.1 years. The most common type of presentation of CIS was optic neuritis (ON). Sixteen (16/32, 50%) patients experienced a second demyelinating event. The mean interval between the first event and the recurrent episode was 21±20 months. The mean follow-up was 6.1±1.6 years. Eleven (34%) patients developed childhood onset multiple sclerosis (MS). In contrast to previous studies, asymptomatic brain lesions on magnetic resonance imaging (MRI) and the presence of cerebrospinal fluid (CSF) oligoclonal bands (OCBs) were not predictors of conversion to MS.
Conclusion:
In our study, a second relapse and initial presentation with brain stem, cerebellar, cerebral dysfunction, or multifocal CIS were strongly associated with the development of MS (p=0.002). Despite clinical definitions and increased understanding of CIS in children, challenges remain in predicting its progression to a chronic demyelinating disease.
Related Concept Videos
Stages of Infection
Atypical Pneumonia
Pharmacokinetics in Pediatric Patients: Drug Excretion
Viral Meningitis
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
